References
- Bibb, M. J. 1996 The regulation of antibiotic production in Streptomyces coelicolor A3(2). Microbiology 142: 1335-1344 https://doi.org/10.1099/13500872-142-6-1335
- Brunton, V. G., G. Steele, A. G. Lewis, and P. Workman. 1998. Geldanamycin induced cytotoxity in human colon-cancer cell lines: Evidence against the involvement of c-Src or DTdiaphorase. Cancer Chemother. Pharmacol. 41: 417-422 https://doi.org/10.1007/s002800050760
- Byrne, K. M., A. Shafiee, J. B. Nielsen, B. H. Arison, R. L. Monaghan, and L. Kaplan. 1993. The biosynthesis and enzymology of an immunosuppressant, immunomycin, produced by Streptomyces hygroscopicus var. ascomyciticus, pp. 29-45. In R. Hamill (ed.), Developments in Industrial Microbiology Series, Vol. 32. Wm. C. Brown Publisher, Dubuque, Iowa
- Chiosis, G., H. Huezo, N. Rosen, E. Mimnaugh, L. Whitesell, and L. Neckers. 2003. 17AAG: Low target binding affinity and potent cell activity - finding an explanation. Mol. Cancer Therap. 2: 123-129
- DeBoer, C. and A. Dietz. 1976. The description and antibiotic production of Streptomyces hygroscopicus var. geldanus. J. Antibiot. (Tokyo) 29: 1182-1188 https://doi.org/10.7164/antibiotics.29.1182
- DeBoer, C., P. A. Meulman, R. J. Wnuk, and D. H. Peterson. 1970. Geldanamycin, a new antibiotic. J. Antibiot. (Tokyo) 23: 442-447 https://doi.org/10.7164/antibiotics.23.442
- Doull, J. C., S. Y. Ayer, A. K. Singh, and P. Thibault. 1993. Production of a novel polyketide antibiotic, jadomycin B, by Streptomyces venezuelae following heat shock. J. Antibiot. 44: 869-871
-
Harber, A., R. D. Johnson, and K. L. Jr. Rinehart. 1977. Biosynthetic origin of the
$C_2$ units of geldanamycin and distribution of labeled form D-[6-$^{13}C$ ]glucose. J. Am. Chem. Soc. 99: 3541-3544 https://doi.org/10.1021/ja00452a079 - Hayes, A., G. Hobbs, C. P. Smith, S. G. Oliver, and P. R. Butler. 1997. Environmental signals triggering methylenomycin production by Streptomyces coelicolor A(3)2. J. Bacteriol. 179: 5511-5515 https://doi.org/10.1128/jb.179.17.5511-5515.1997
- Kieser, T., M. J. Bibb, M. J. Buttner, K. F. Chater, and D. A. Hopwood. 2000. Practical Streptomyces Genetics. John Innes Foundation, Norwich
- Kim, C. J., Y. K. Chang, and G.-T. Chun. 2000. Enhancement of kasugamycin production by pH shock in batch cultures of Streptomyces kasugaensis. Biotech. Prog. 16: 548-552 https://doi.org/10.1021/bp000038f
- Kim, Y. J., J. Y. Song, M. H. Moon, C. P. Smith, S.-K. Hong. and Y. K. Chang. 2007. pH shock induces overexpression of regulatory and biosynthetic genes for actinorhodin production in Streptomyces coelicolor A3(2). Appl. Microbiol. Biotechnol. 76: 1119-1130 https://doi.org/10.1007/s00253-007-1083-9
- Sausville, E. A., J. E. Tomaszewski, and P. Ivy. 2003. Clinical development of 17-allyamino, 17-demethoxygeldanamycin. Curr. Cancer Drug Targets 3: 377-383 https://doi.org/10.2174/1568009033481831
- Sevcikova, B. and J. Kormanec. 2004. Differential production of two antibiotics of Streptomyces coelicolor A3(2), actinorhodin and undecylprodigiosin, upon salt stress conditions. Arch. Microbiol. 181: 384-389 https://doi.org/10.1007/s00203-004-0669-1
- Supko, J. G., R. L. Hickman, M. R. Grever, and L. Malspeis. 1995. Preclinical phamacologenic evaluation of geldanamycin as an antitumor agent. Cancer Chemother. Pharmacol. 36: 305-315 https://doi.org/10.1007/BF00689048
- Workman, P. 2003. Auditing the pharmacological account for Hsp90 molecular chaperone inhibitor: Unfolding the relationship between pharmacokinetics and pharmacodynamics. Mol. Cancer Therap. 2: 131-138